Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
Clinical trial NCT00529516 · COMPLETED
Trial details
- NCT number
- NCT00529516
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-15
- Primary completion
- 2007-12-21
- Enrollment
- 1252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.